Kilpest India trades jubilantly on selling 16,54,000 Covid19 RT-PCR test kits in April 2021

03 May 2021 Evaluate

Kilpest India is currently trading at Rs. 453.20, up by 41.20 points or 10.00% from its previous closing of Rs. 412.00 on the BSE.

The scrip opened at Rs. 445.00 and has touched a high and low of Rs. 453.20 and Rs. 426.10 respectively. So far 58704 shares were traded on the counter.

The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 517.00 on 12-Aug-2020 and a 52 week low of Rs. 117.15 on 05-Jun-2020.

Last one week high and low of the scrip stood at Rs. 489.90 and Rs. 390.00 respectively. The current market cap of the company is Rs. 334.86 crore.

The promoters holding in the company stood at 38.35%, while Institutions and Non-Institutions held 1.10% and 60.55% respectively.

Kilpest India has sold 16,54,000 COVID-19 RT-PCR Tests in the month of April, 2021 with an average price of Rs 80 per test. Also Exports against Licenses received worth Rs 32,00,000 was done in April, 2021.

Kilpest India is one of India's leading agri-based companies. The Company manufactures, imports, exports, buys, and sells biological compounds derived from plants, animals, micro organisms.

 

3B Blackbio Dx Share Price

758.65 -6.85 (-0.89%)
19-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
UPL 487.00
BASF India 3622.60
PI Industries 3714.95
Bayer CropScience 5760.00
Sumitomo Chemical India 400.60
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.